· Periodic Report
Q3 profit from main business KRW 3.8 billion on sales of KRW 129.9 billion
Dong Wha Pharm sold KRW 129.9 billion in Q3 and earned KRW 3.8 billion from its main business, up 179.5% from a year earlier and down 62.8% from the prior quarter.